CS MEDICA A/S announced an agreement with Nabih Nabulsi Drugstores. This new partnership entails the distribution of 100,000 units spanning all nine products of the CANNASEN brand, marking the brand's launch on the global markets today. The connection between CS MEDICA and Nabih Nabulsi Drug stores was established at the CPHI conference in Barcelona in October, culminating in this strategic agreement.

The contract outlines a comprehensive plan to introduce the CAN NASEN brand into the Jordan market, leveraging Nabih Nabulsi Drugstore' extensive expertise and dominant presence in the medical device market in Jordan. This distributor is also recognized for its influential partnerships in pharmaceuticals, diagnostics, and medical devices, serving an extensive pharmaceutical channel and key opinion leaders (KOLs). The registration process of the products is expected to take 6-8 months, with production anticipated to span approximately 2-3 months.

Notably, CS MEDICA has implemented a strategy to reduce the lead time to market for this launch. By paralleling the product registration process the company will create a ready-to-order design specifically adjusted for Jordan. This proactive approach ensures that production can commence immediately once registration is finalized, facilitating a swift market entry.

The agreement is structured on an ex-work basis, with activation set at 80% payment upon completion of the registration and the remainder to be finalized before pickup.